NEW YORK (GenomeWeb News) – The National Cancer Institute is offering to fund researchers studying ways of using emerging cellular, molecular, and genomics technologies in cancer care.
These research programs will assess these technologies for how they work in regards to quality of care, cost-effectiveness, influence on cancer outcomes, progression, survival, and mortality, and in other ways, NCI said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.